10x Genomics, Inc.
TXG
$61.65
$1.672.78%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 616.91M | 638.78M | 642.82M | 641.81M | 644.47M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 616.91M | 638.78M | 642.82M | 641.81M | 644.47M |
| Cost of Revenue | 184.78M | 194.07M | 198.84M | 200.02M | 196.59M |
| Gross Profit | 432.13M | 444.71M | 443.98M | 441.79M | 447.88M |
| SG&A Expenses | 292.71M | 288.48M | 311.83M | 331.54M | 338.59M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 704.10M | 713.59M | 749.11M | 781.20M | 793.79M |
| Operating Income | -87.18M | -74.80M | -106.29M | -139.38M | -149.33M |
| Income Before Tax | -74.89M | -19.25M | -39.91M | -73.09M | -79.33M |
| Income Tax Expenses | 235.00K | 3.41M | 3.64M | 3.23M | 5.27M |
| Earnings from Continuing Operations | -75.13 | -22.66 | -43.54 | -76.32 | -84.60 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -75.13M | -22.66M | -43.54M | -76.32M | -84.60M |
| EBIT | -87.18M | -74.80M | -106.29M | -139.38M | -149.33M |
| EBITDA | -47.20M | -36.67M | -70.09M | -104.50M | -115.78M |
| EPS Basic | -0.59 | -0.17 | -0.35 | -0.62 | -0.70 |
| Normalized Basic EPS | -0.36 | -0.27 | -0.43 | -0.61 | -0.66 |
| EPS Diluted | -0.59 | -0.17 | -0.35 | -0.62 | -0.70 |
| Normalized Diluted EPS | -0.36 | -0.27 | -0.43 | -0.61 | -0.66 |
| Average Basic Shares Outstanding | 510.86M | 504.63M | 498.94M | 493.46M | 488.69M |
| Average Diluted Shares Outstanding | 510.86M | 505.38M | 499.70M | 494.21M | 489.45M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |